Log In
Print this Print this

Fabrazyme, agalsidase beta

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionAgalsidase beta
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today